Healthcare - Biotechnology - NASDAQ - US
$ 2.21
-0.897 %
$ 1.9 M
Market Cap
-0.14
P/E
CASH FLOW STATEMENT
-10.7 M
OPERATING CASH FLOW
-5 K
INVESTING CASH FLOW
7.41 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Phio Pharmaceuticals Corp.
| Net Income | -10.8 M |
| Depreciation & Amortization | 184 K |
| Capital Expenditures | -5 K |
| Stock-Based Compensation | 303 K |
| Change in Working Capital | -536 K |
| Others | -288 K |
| Free Cash Flow | -10.8 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (10.8) | (11.5) | (13.3) | (8.8) | (8.9) | (7.4) | (12.5) | (9.0) | (10.2) | (8.8) | (20.9) | (12.9) | (10.2) |
| Depreciation & Amortization | 0.2 | 0.2 | 75 K | 72 K | 67 K | 81 K | 70 K | 53 K | 77 K | 87 K | 99 K | 0.1 | 0.2 |
| Deferred Income Tax | 0 | (0.3) | (0.2) | 0 | 0 | 0 | (1.6) | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0.3 | 0.4 | 0.5 | 0.1 | 0.3 | 0.3 | 0.3 | 0.8 | 1.5 | 1.8 | 2.0 | 1.0 | 2.1 |
| Other Operating Activities | 0.1 | 0.3 | 0.1 | 0.1 | 0.1 | 0.4 | 4.7 | 9 K | 0.2 | 10 K | 12.2 | 6.2 | (2.4) |
| Change in Working Capital | (0.5) | (1.3) | 1.0 | (0.3) | (0.2) | (0.5) | (0.5) | 0.4 | 1.1 | (0.9) | 0.3 | 0.5 | 0.3 |
| Cash From Operations | (10.7) | (12.1) | (11.9) | (8.8) | (8.6) | (7.5) | (9.5) | (7.8) | (7.3) | (7.8) | (6.3) | (5.1) | (10.0) |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | 5 K | (0.1) | 51 K | 19 K | 72 K | 5 K | (0.2) | 4 K | 57 K | 95 K | 78 K | 15 K | 59 K |
| Other Items | 0 | 0 | 0 | 0 | 0 | 0 | 100 K | 5.3 | (5.5) | 3.0 | (3.0) | 31 K | 53 K |
| Cash From Investing Activities | 5 K | (0.1) | 51 K | 19 K | 72 K | 5 K | (0.1) | 5.3 | (5.6) | 2.9 | (3.1) | 16 K | (0.1) |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | 13 K | 28 | 0 | 15 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0.2 | 6 K | 0 | 0 | 0 | 0 | 0 | 5 K | 0.5 | 0.4 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.2) | (4.1) | 0 | 0 | 0 |
| Other Financing Activities | 28 K | 26 K | 2.1 | 3.9 | 69 K | 0 | 0 | 0 | 9.5 | 4.1 | 7 K | 17.7 | 3.3 |
| Cash From Financing Activities | 7.4 | 26 K | 21.7 | 16.1 | 0.8 | 18.8 | 0.3 | 10.2 | 9.5 | 1.9 | 15.7 | 9.7 | 3.7 |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | (3.3) | (12.3) | 9.8 | 7.3 | (7.9) | 11.3 | (9.3) | 7.8 | (3.4) | (2.9) | 6.3 | 4.6 | (6.4) |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | (10.8) | (12.2) | (11.9) | (8.8) | (8.7) | (7.5) | (9.7) | (7.8) | (7.4) | (7.9) | (6.4) | (5.1) | (10.0) |